Corticosteroid replacement by ruxolitinib in patients with acute GVHD experiencing severe steroid-induced side effects

Bone Marrow Transplant. 2020 Jan;55(1):253-255. doi: 10.1038/s41409-019-0526-0. Epub 2019 Apr 10.

Authors

Elizabeth A de Kort¹, Suzanne van Dorp¹, Nicole M A Blijlevens¹, Walter J F M van der Velden²

Affiliations

¹ Department of Hematology, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, Netherlands.
² Department of Hematology, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, Netherlands. [email protected].

PMID: 30971779
DOI: 10.1038/s41409-019-0526-0

No abstract available

Publication types

Letter

MeSH terms

Acute Disease
Adrenal Cortex Hormones / adverse effects
Graft vs Host Disease* / drug therapy
Humans
Nitriles
Pyrazoles / adverse effects
Pyrimidines
Steroids

Substances

Adrenal Cortex Hormones
Nitriles
Pyrazoles
Pyrimidines
Steroids
ruxolitinib